Table of Contents Securities registered pursuant to Section 12(b) of the Act: Title Of Each Class Trading Symbol(s) Name Of Each Exchange On Which Registered Common Shares of Beneficial Interest DHC The Nasdaq Stock Market LLC 5.625% Senior Notes due 2042 DHCNI The Nasdaq Stock Market LLC 6.25% Senior Notes due 2046 DHCNL The Nasdaq Stock Market LLC Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐ UNITED STATES SECURITIES AND EXCHANG ...

Financial Results [Second Quarter 2024 Financial Results Announcement](index=3&type=section&id=Diversified%20Healthcare%20Trust%20Announces%20Second%20Quarter%202024%20Financial%20Results) Diversified Healthcare Trust (DHC) announced strong second quarter 2024 financial results, exceeding normalized FFO expectations due to revenue growth and expense management - DHC exceeded **normalized FFO expectations** in Q2 2024, driven by revenue growth and expense management[2](index=2&type=chunk) - **SHOP same property NOI increased 27% year-over-year**, supported by occupancy and rent growths[2](index=2&type=chunk) - Medical Office and Life Science Portfolio achieved a **12% increase in weighted average rental rates** on over 100,000 square feet of leasing, marking the **fourth consecutive quarter of double-digit rent growth**[2](index=2&type=chunk) [Second Quarter 2024 Highlights](index=4&type=section&id=Second%20Quarter%202024%20Highlights) The second quarter of 2024 saw a net loss of $97.9 million, but normalized FFO reached $6.8 million, with operational highlights including significant growth in SHOP Same Property Cash Basis NOI and Medical Office and Life Science Portfolio leasing activity, alongside strategic financing and property disposition activities to strengthen liquidity Key Financial Highlights | Metric | Value (in millions USD) | | :--------------------- | :------------------ | | Net loss | $(97.9) | | Normalized FFO | $6.8 | Same Property Cash Basis NOI (QoQ Change) | Segment | June 30, 2024 (thousands USD) | March 31, 2024 (thousands USD) | Change | | :---------------------------------- | :-------------------------- | :--------------------------- | :------- | | Medical Office and Life Science Portfolio | 30,784 | 30,544 | 0.8 % | | SHOP | 30,378 | 25,908 | 17.3 % | | Consolidated | 68,817 | 64,087 | 7.4 % | - Leased **101,047 square feet** in DHC's Medical Office and Life Science Portfolio at weighted average rental rates **12% higher than prior rents** for the same space[7](index=7&type=chunk) - Year-over-year second quarter SHOP occupancy increased **120 basis points to 79.0%** and average monthly rates increased **6.1%**, resulting in an **8.3% increase in SHOP revenues**[7](index=7&type=chunk) - Executed a **$120.0 million CMBS financing**, with **$60.0 million** used to partially redeem DHC's outstanding **$500.0 million senior unsecured notes due 2025**[7](index=7&type=chunk) [Second Quarter 2024 Results](index=5&type=section&id=Second%20Quarter%202024%20Results) DHC reported a net loss of $97.9 million for Q2 2024, an increase from Q1 2024, while Normalized FFO significantly improved by 93.9%, with occupancy rates showing mixed trends, including a slight increase in SHOP but a decrease in Medical Office and Life Science Portfolio Key Financial Results (QoQ Comparison) | Metric (dollars in thousands, except per share data) | June 30, 2024 | March 31, 2024 | Change | | :--------------------------------------------------- | :------------ | :------------- | :------- | | Net loss | $(97,861) | $(86,259) | (13.5)% | | Net loss per share | $(0.41) | $(0.36) | (13.9)% | | Normalized FFO | $6,830 | $3,523 | 93.9 % | | Normalized FFO per share | $0.03 | $0.01 | 200.0 % | | Adjusted EBITDAre | $68,895 | $64,060 | 7.5 % | Occupancy Rates (QoQ Comparison) | Occupancy | June 30, 2024 | March 31, 2024 | Basis Point Change | | :---------------------------------------- | :------------ | :------------- | :----------------- | | Medical Office and Life Science Portfolio | 81.5% | 82.9% | (140) | | SHOP | 79.0% | 78.9% | 10 | | Same Property Occupancy | | | | | Medical Office and Life Science Portfolio | 87.4% | 90.1% | (270) | | SHOP | 79.6% | 79.4% | 20 | Financials [Key Financial Data](index=6&type=section&id=Key%20Financial%20Data) DHC's key financial data for Q2 2024 shows a slight decrease in total assets and equity compared to previous quarters, while total liabilities increased, total revenues saw a modest increase, but net loss widened, Normalized FFO improved significantly quarter-over-quarter, and the annualized dividend remained stable Selected Balance Sheet Data (QoQ) | Metric (dollars in thousands) | 6/30/2024 | 3/31/2024 | 6/30/2023 | | :---------------------------- | :---------- | :---------- | :---------- | | Total assets | $5,333,447 | $5,348,037 | $5,585,475 | | Total liabilities | $3,184,133 | $3,099,334 | $3,076,086 | | Total equity | $2,149,314 | $2,248,703 | $2,509,389 | Selected Income Statement Data (QoQ) | Metric (dollars in thousands) | 6/30/2024 | 3/31/2024 | 6/30/2023 | | :---------------------------- | :-------- | :-------- | :-------- | | Total revenues | 371,392 | 370,776 | 346,219 | | Net loss | (97,861) | (86,259) | (72,571) | | NOI | 67,327 | 63,172 | 59,991 | | Adjusted EBITDAre | 68,895 | 64,060 | 62,136 | | FFO | 14,563 | 2,588 | 6,090 | | Normalized FFO | 6,830 | 3,523 | 12,133 | | CAD | (5,766) | 2,411 | (13,317) | Per Share Data and Dividends (QoQ) | Metric (basic and diluted) | 6/30/2024 | 3/31/2024 | 6/30/2023 | | :------------------------------------ | :-------- | :-------- | :-------- | | Net loss | (0.41) | (0.36) | (0.30) | | FFO | 0.06 | 0.01 | 0.03 | | Normalized FFO | 0.03 | 0.01 | 0.05 | | CAD | (0.02) | 0.01 | (0.06) | | Annualized dividend declared per share | 0.04 | 0.04 | 0.04 | [Condensed Consolidated Balance Sheets](index=7&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of June 30, 2024, DHC's total assets decreased to $5.33 billion from $5.45 billion at year-end 2023, primarily due to a reduction in net real estate properties, total liabilities increased to $3.18 billion, driven by higher senior secured and secured debt, while total shareholders' equity declined Condensed Consolidated Balance Sheet (June 30, 2024 vs. Dec 31, 2023) | Asset (dollars in thousands) | June 30, 2024 | December 31, 2023 | | :------------------------------------------- | :------------ | :---------------- | | Total real estate properties, gross | $6,761,922 | $6,818,467 | | Total real estate properties, net | $4,654,984 | $4,797,624 | | Investments in unconsolidated joint ventures | $108,806 | $129,916 | | Assets of properties held for sale | $43,969 | $9,447 | | Cash and cash equivalents | $265,563 | $245,939 | | Total assets | $5,333,447 | $5,446,136 | | | | | | Liability (dollars in thousands) | June 30, 2024 | December 31, 2023 | | :------------------------------------------- | :------------ | :---------------- | | Senior secured notes, net | $776,262 | $731,211 | | Senior unsecured notes, net | $2,015,093 | $2,072,618 | | Secured debt and finance leases, net | $128,560 | $13,020 | | Total liabilities | $3,184,133 | $3,109,245 | | Total shareholders' equity | $2,149,314 | $2,336,891 | [Condensed Consolidated Statements of Income (Loss)](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income%20(Loss)) For Q2 2024, DHC reported total revenues of $371.4 million, up from $346.2 million in Q2 2023, however, total expenses also increased, leading to a net loss of $97.9 million, wider than the $72.6 million loss in Q2 2023, with the loss significantly impacted by a $13.2 million loss on sale of properties and $12.3 million in equity in net losses of investees Condensed Consolidated Statements of Income (Loss) (Q2 2024 vs. Q2 2023) | Metric (amounts in thousands, except per share data) | Q2 2024 | Q2 2023 | YTD 2024 | | :--------------------------------------------------- | :---------- | :---------- | :---------- | | Total revenues | $371,392 | $346,219 | $742,168 | | Property operating expenses | $304,065 | $286,228 | $611,669 | | Depreciation and amortization | $68,357 | $68,394 | $138,490 | | General and administrative | $6,262 | $7,284 | $13,830 | | Impairment of assets | $6,545 | $11,299 | $18,687 | | Total expenses | $387,055 | $379,248 | $784,588 | | (Loss) gain on sale of properties | $(13,213) | $1 | $(19,087) | | Interest expense | $(58,702) | $(47,384) | $(116,278) | | Equity in net (losses) earnings of investees | $(12,307) | $2,929 | $(10,409) | | Net loss | $(97,861) | $(72,571) | $(184,120) | | Net loss per common share | $(0.41) | $(0.30) | $(0.77) | [Condensed Consolidated Statements of Income (Loss) (Additional Data)](index=9&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income%20(Loss)%20(Additional%20Data)) Additional income statement data for Q2 2024 reveals non-cash adjustments impacting rental income and expenses, notably, non-cash straight line rent adjustments were positive $656 thousand, a significant change from a negative $4.46 million in Q2 2023, business management incentive fees were a negative $849 thousand, while non-cash share-based compensation increased Additional Income Statement Data (Q2 2024 vs. Q2 2023) | Metric (dollars in thousands) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |\n| :----------------------------------------------------------- | :------ | :-------- | :------- | :------- |\n| Business management incentive fees | $(849) | $0 | $0 | $0 |\n| Non-cash straight line rent adjustments included in rental income | $656 | $(4,457) | $947 | $(2,009) |\n| Lease value amortization included in rental income | $(29) | $(25) | $(57) | $(50) |\n| Lease termination fees included in rental income | $0 | $2,183 | $203 | $2,487 |\n| Non-cash share based compensation | $940 | $565 | $1,498 | $834 | Debt and Leverage [Debt Summary](index=10&type=section&id=Debt%20Summary) As of June 30, 2024, DHC's total debt stood at $3.11 billion, comprising $2.04 billion in unsecured fixed rate debt and $1.07 billion in secured fixed rate debt, with the weighted average interest rate for total debt at 4.304%, and a new $120.0 million mortgage secured by eight properties executed in May 2024 Debt Summary as of June 30, 2024 | Debt Type | Coupon Rate | Interest Rate | Principal Balance (thousands USD) | Maturity Date |\n| :------------------------- | :---------- | :------------ | :------------------------------ | :------------ |\n| **Unsecured Fixed Rate Debt:** | | | | |\n| Senior unsecured notes due 2025 | 9.750% | 9.750% | $440,000 | 6/15/2025 |\n| Senior unsecured notes due 2028 | 4.750% | 4.966% | $500,000 | 2/15/2028 |\n| Senior unsecured notes due 2031 | 4.375% | 4.375% | $500,000 | 3/1/2031 |\n| Senior unsecured notes due 2042 | 5.625% | 5.625% | $350,000 | 8/1/2042 |\n| Senior unsecured notes due 2046 | 6.250% | 6.250% | $250,000 | 2/1/2046 |\n| Weighted average rate / total unsecured fixed rate debt | 6.070% | 6.123% | $2,040,000 | |\n| **Secured Fixed Rate Debt:** | | | | |\n| Senior secured notes due 2026 | 0.000% | 0.000% | $940,534 | 1/15/2026 |\n| Finance leases - 2 properties | 7.700% | 7.700% | $3,140 | 4/30/2026 |\n| Mortgage - secured by eight properties | 6.864% | 6.864% | $120,000 | 6/11/2034 |\n| Mortgage - secured by one property | 6.444% | 6.444% | $8,294 | 7/6/2043 |\n| Weighted average rate / total secured fixed rate debt | 0.841% | 0.841% | $1,071,968 | |\n| **Total Debt:** | 4.269% | 4.304% | **$3,111,968** | | - In May 2024, DHC executed a **$120.0 million fixed rate, interest-only mortgage loan** secured by eight properties[13](index=13&type=chunk) [Debt Maturity Schedule](index=11&type=section&id=Debt%20Maturity%20Schedule) DHC's debt maturity schedule as of June 30, 2024, indicates significant maturities in 2025 and 2026, primarily driven by unsecured fixed rate debt and senior secured notes, with the majority of debt maturing in the near to medium term - The largest debt maturities are concentrated in **2025 ($440 million unsecured)** and **2026 ($941.4 million secured)**[14](index=14&type=chunk) - Unsecured fixed rate debt has maturities spread from **2025 to 2046**, while secured fixed rate debt has maturities from **2026 to 2043**[13](index=13&type=chunk)[14](index=14&type=chunk) [Leverage Ratios, Coverage Ratios and Bond Covenants](index=12&type=section&id=Leverage%20Ratios,%20Coverage%20Ratios%20and%20Bond%20Covenants) As of June 30, 2024, DHC's leverage ratios showed a slight decrease in net debt/total gross assets to 38.3% from 38.4% in Q1 2024, while secured debt/total assets increased to 20.1%, coverage ratios improved, with net debt/annualized Adjusted EBITDAre at 10.2x and Adjusted EBITDAre/interest expense at 1.2x, and DHC remained compliant with all bond covenants Leverage Ratios (QoQ) | Metric | 6/30/2024 | 3/31/2024 | 6/30/2023 |\n| :-------------------------------------- | :-------- | :-------- | :-------- |\n| Net debt / total gross assets | 38.3% | 38.4% | 32.8% |\n| Net debt / gross book value of real estate assets | 39.5% | 39.5% | 34.5% |\n| Secured debt / total assets | 20.1% | 17.8% | 8.3% |\n| Variable rate debt / net debt | -% | —% | 18.3% | Coverage Ratios (QoQ) | Metric | 6/30/2024 | 3/31/2024 | 6/30/2023 |\n| :-------------------------------------- | :-------- | :-------- | :-------- |\n| Net debt / annualized Adjusted EBITDAre | 10.2x | 10.8x | 9.8x |\n| Adjusted EBITDAre / interest expense | 1.2x | 1.1x | 1.3x | Bond Covenants (Compliance) | Covenant | 6/30/2024 | Required Minimum/Allowable Maximum |\n| :-------------------------------------------------------------------- | :-------- | :--------------------------------- |\n| Total unencumbered assets / unsecured debt | 267.5% | 150.0% |\n| Total debt / adjusted total assets | 41.2% | 80.0% |\n| Secured debt / adjusted total assets | 14.2% | 40.0% |\n| Consolidated income available for debt service / debt service | 1.76x | 1.50x | Investments [Summary of Capital Expenditures](index=13&type=section&id=Summary%20of%20Capital%20Expenditures) Total capital expenditures for Q2 2024 were $41.3 million, a significant increase from $25.9 million in Q1 2024, primarily driven by higher SHOP fixed assets and capital improvements, as well as increased development and redevelopment activities in the SHOP segment Total Capital Expenditures by Segment (QoQ) | Segment | Q2 2024 (thousands USD) | Q1 2024 (thousands USD) |\n| :---------------------------------------- | :-------------------- | :-------------------- |\n| Medical Office and Life Science Portfolio | $9,373 | $7,661 |\n| SHOP | $27,328 | $11,280 |\n| Wellness centers | $4,591 | $6,923 |\n| **Total capital expenditures** | **$41,292** | **$25,864** | Recurring Capital Expenditures (QoQ) | Type | Q2 2024 (thousands USD) | Q1 2024 (thousands USD) |\n| :----------------------------------------------------------------- | :-------------------- | :-------------------- |\n| Recurring capital expenditures - Medical Office and Life Science Portfolio | $8,261 | $6,948 |\n| SHOP fixed assets and capital improvements | $21,623 | $10,091 |\n| Wellness centers lease related costs | $4,591 | $6,923 |\n| **Total recurring capital expenditures** | **$34,475** | **$23,962** | Development, Redevelopment and Other Activities (QoQ) | Segment | Q2 2024 (thousands USD) | Q1 2024 (thousands USD) |\n| :---------------------------------------------------------- | :-------------------- | :-------------------- |\n| Development, redevelopment and other activities - Medical Office and Life Science Portfolio | $1,112 | $713 |\n| Development, redevelopment and other activities - SHOP | $5,705 | $1,189 |\n| **Total development, redevelopment and other activities** | **$6,817** | **$1,902** | [Redevelopment Information](index=14&type=section&id=Redevelopment%20Information) DHC has no significant ongoing redevelopments in its Medical Office and Life Science Portfolio as of June 30, 2024, however, the SHOP segment has several active redevelopment projects, including Pueblo Norte Senior Living and Five Star Premier Residences of Teaneck, along with 23 refresh projects, with total estimated project costs of $61.9 million - DHC does not have any significant ongoing redevelopments in its Medical Office and Life Science Portfolio as of June 30, 2024[16](index=16&type=chunk) SHOP Redevelopment Projects as of June 30, 2024 | Project | Location | Type of Property | Number of Units | Estimated Project Costs (millions USD) | Total Costs Incurred as of June 30, 2024 (millions USD) |\n| :------------------------------------ | :------------ | :--------------- | :-------------- | :----------------------------------- | :---------------------------------------------------- |\n| Pueblo Norte Senior Living | Scottsdale, AZ | IL/AL | 197 | $26.6 | $15.9 |\n| Five Star Premier Residences of Teaneck | Teaneck, NJ | IL/AL | 218 | $10.3 | $10.2 |\n| 23 refresh projects | Various | IL/AL/MC | 3,873 | $25.0 | $0.2 |\n| **Total** | | | | **$61.9** | **$26.3** | [Property Acquisitions / Dispositions Information Since January 1, 2024](index=15&type=section&id=Property%20Acquisitions%20%2F%20Dispositions%20Information%20Since%20January%201,%202024) DHC has not acquired any properties since January 1, 2024, however, it completed four property dispositions, all Medical Office properties, for a total gross sales price of $29.075 million, with two sales occurring in Q2 and two in July 2024 - DHC has not acquired any properties since January 1, 2024[18](index=18&type=chunk) Property Dispositions Since January 1, 2024 | Date Sold | Location | Type of Property | Number of Properties | Gross Sales Price (thousands USD) |\n| :-------- | :---------------- | :--------------- | :------------------- | :------------------------------ |\n| 3/28/2024 | Phoenix, AZ | Medical Office | 1 | $3,600 |\n| 6/3/2024 | Irving, TX | Medical Office | 1 | $4,200 |\n| 7/22/2024 | Buffalo Grove, IL | Medical Office | 1 | $6,175 |\n| 7/31/2024 | Eagan, MN | Medical Office | 1 | $15,100 |\n| **Total Dispositions** | | | **4** | **$29,075** | [Investments in Unconsolidated Joint Ventures](index=16&type=section&id=Investments%20in%20Unconsolidated%20Joint%20Ventures) DHC holds equity interests in two unconsolidated joint ventures: Seaport Innovation LLC (10% ownership) and The LSMD Fund REIT LLC (20% ownership), totaling 11 properties and 2.2 million square feet with 98% weighted average occupancy, these joint ventures have secured debt totaling $1.08 billion, with a weighted average coupon rate of 4.223% Investments in Unconsolidated Joint Ventures (as of June 30, 2024) | Joint Venture | Location | Type of Property | Number of Properties | Square Feet | Occupancy | Lease Term | DHC Ownership |\n| :--------------------- | :---------- | :--------------- | :------------------- | :---------- | :-------- | :--------- | :------------ |\n| Seaport Innovation LLC | Boston, MA | Life Science | 1 | 1,134,479 | 100% | 4.6 years | 10% |\n| The LSMD Fund REIT LLC | Various | Medical Office / Life Science | 10 | 1,068,763 | 97% | 6.0 years | 20% |\n| **Total / Weighted Average** | | | **11** | **2,203,242** | **98%** | **5.1 years** | | Unconsolidated Joint Ventures Secured Debt (as of June 30, 2024) | Joint Venture | Secured Debt Type | Coupon Rate | Maturity Date | Principal Balance (thousands USD) |\n| :--------------------- | :--------------------- | :---------- | :------------ | :------------------------------ |\n| Seaport Innovation LLC | Fixed Rate - 1 Property | 3.530% | 11/6/2028 | $620,000 |\n| The LSMD Fund REIT LLC | Fixed Rate - 9 Properties | 3.457% | 2/11/2032 | $189,800 |\n| The LSMD Fund REIT LLC | Floating Rate - 1 Property | 6.380% | 2/9/2025 | $266,825 |\n| **Total / Weighted Average** | | **4.223%** | | **$1,076,625** | - The lease expiration schedule for unconsolidated joint ventures shows **63.3% of total annualized rental income expiring in 2028**, with major tenants including Vertex Pharmaceuticals, Cedars-Sinai Medical Center, and Seattle Genetics[30](index=30&type=chunk) Portfolio Information [Portfolio Summary by Geographic Diversification and Property Type](index=18&type=section&id=Portfolio%20Summary%20by%20Geographic%20Diversification%20and%20Property%20Type) DHC's portfolio is geographically diversified across 36 states and Washington, D.C., with Florida (10%), California (9%), and Texas (9%) being the largest states by gross book value, and by Q2 2024 NOI, the portfolio is primarily composed of Independent Living (30%), Medical Office (29%), and Assisted Living (19%) properties - Geographic diversification (based on Gross Book Value of Real Estate Assets as of June 30, 2024): **FL: 10%, CA: 9%, TX: 9%, GA: 7%**, 26 Other States + D.C.: 41%[31](index=31&type=chunk) - Property type diversification (based on Q2 2024 NOI): **Independent Living: 30%, Medical Office: 29%, Assisted Living: 19%**, Life Science: 15%, SNFs: 2%[32](index=32&type=chunk) [Portfolio Summary](index=19&type=section&id=Portfolio%20Summary) As of June 30, 2024, DHC's portfolio comprised 370 properties with a total gross book value of $7.2 billion, with the SHOP segment representing the largest portion with 232 properties and $4.56 billion in gross book value, contributing 83.1% of Q2 2024 total revenues and 43.0% of Q2 2024 NOI Portfolio Summary as of June 30, 2024 | Property Type | Number of Properties | Square Feet or Number of Units | Gross Book Value of Real Estate Assets (thousands USD) | % of Total Gross Book Value | Q2 2024 Revenues (thousands USD) | % of Q2 2024 Total Revenues | Q2 2024 NOI (thousands USD) |\n| :--------------------------------- | :------------------- | :----------------------------- | :--------------------------------------------------- | :-------------------------- | :----------------------------- | :-------------------------- | :------------------------ |\n| Life science | 23 | 2,562,464 sq. ft. | $785,122 | 10.9 % | $16,604 | 4.5 % | $9,831 |\n| Medical office | 78 | 5,834,481 sq. ft. | $1,453,863 | 20.2 % | $37,951 | 10.2% | $20,442 |\n| Subtotal Medical Office and Life Science Portfolio | 101 | 8,396,945 sq. ft. | $2,238,985 | 31.1 % | $54,555 | 14.7 % | $30,273 |\n| SHOP | 232 | 25,230 units | $4,557,303 | 63.3 % | $308,522 | 83.1 % | $28,984 |\n| Triple net leased senior living communities | 27 | 2,062 units | $202,766 | 2.8% | $5,234 | 1.4% | $5,233 |\n| Wellness centers | 10 | 812,000 sq.ft. | $199,007 | 2.8 % | $3,081 | 0.8 % | $2,837 |\n| **Total** | **370** | | **$7,198,061** | **100.0 %** | **$371,392** | **100.0 %** | **$67,327** | [SHOP Units by Operator](index=20&type=section&id=SHOP%20Units%20by%20Operator) DHC's SHOP segment comprises 230 properties with 25,230 units, predominantly managed by Five Star Senior Living (119 properties, 17,654 units), with the unit mix primarily Independent Living (41.1%) and Assisted Living (41.9%), and smaller proportions of Memory Care and Skilled Nursing SHOP Units by Operator as of June 30, 2024 | Manager | Number of Properties | Assisted Living | Independent Living and Active Adult | Memory Care | Skilled Nursing | Unit Count as of June 30, 2024 |\n| :------------------------ | :------------------- | :-------------- | :---------------------------------- | :---------- | :-------------- | :----------------------------- |\n| Five Star Senior Living | 119 | 6,459 | 9,640 | 1,555 | - | 17,654 |\n| Oaks-Caravita Senior Care | 26 | 1,061 | 40 | 314 | 1,415 | 2,830 |\n| Phoenix Senior Living | 23 | 961 | 147 | 214 | 164 | 1,486 |\n| Charter Senior Living | 30 | 1,338 | - | 422 | - | 1,760 |\n| Stellar Senior Living | 10 | 1 | 177 | - | 917 | 1,095 |\n| Northstar Senior Living | 7 | 121 | 1 | 297 | - | 419 |\n| Navion Senior Solutions | 5 | 213 | = | 25 | = | 238 |\n| Life Care Services | 3 | 73 | 194 | 12 | 238 | 517 |\n| Oaks Senior Living | 3 | 159 | I | 105 | = | 265 |\n| IntegraCare Senior Living | 2 | 113 | - | 33 | = | 146 |\n| Omega Senior Living | 1 | 14 | - | - | = | 14 |\n| The RMR Group | 1 | 1 | 169 | 1 | B | 171 |\n| **Total** | **230** | **10,567** | **10,367** | **2,977** | **1,319** | **25,230** |\n| **% of Total** | | **41.9%** | **41.1%** | **11.8%** | **5.2%** | | [Senior Living NOI by Manager](index=21&type=section&id=Senior%20Living%20NOI%20by%20Manager) Five Star Senior Living is the largest contributor to DHC's senior living NOI, accounting for $23.66 million or 69.1% of the total $34.22 million in Q2 2024, with other significant contributors including Phoenix Senior Living and Stellar Senior Living Senior Living NOI by Manager (Q2 2024) | Manager | Number of Properties | SHOP NOI (thousands USD) | Triple Net Leased Senior Living Communities NOI (thousands USD) | Total NOI (thousands USD) | % of Total Q2 2024 NOI |\n| :------------------------ | :------------------- | :--------------------- | :------------------------------------------------------------ | :---------------------- | :--------------------- |\n| Five Star Senior Living | 119 | $23,659 | $0 | $23,659 | 69.1% |\n| Phoenix Senior Living | 23 | $2,556 | $0 | $2,556 | 7.5% |\n| Stellar Senior Living | 14 | $1,251 | $1,048 | $2,299 | 6.7% |\n| Brookdale Senior Living | 18 | $0 | $2,026 | $2,026 | 5.9% |\n| Charter Senior Living | 30 | $1,388 | $0 | $1,388 | 4.1% |\n| Stratford Retirement | 1 | $0 | $1,149 | $1,149 | 3.4% |\n| Oaks Senior Living | 3 | $1,011 | $0 | $1,011 | 3.0% |\n| Northstar Senior Living | 7 | $743 | $0 | $743 | 2.2% |\n| Navion Senior Solutions | 5 | $537 | $0 | $537 | 1.6% |\n| Covenant Care | 1 | $0 | $508 | $508 | 1.5% |\n| Remaining | 38 | $(2,161) | $502 | $(1,659) | (5.0)% |\n| **Total** | **259** | **$28,984** | **$5,233** | **$34,217** | **100.0%** | [Senior Living Results of Operations by Location](index=22&type=section&id=Senior%20Living%20Results%20of%20Operations%20by%20Location) DHC's SHOP segment reported a total NOI of $29.0 million in Q2 2024, a 26.6% increase year-over-year, with an average occupancy of 79.0% and an average monthly rate of $5,161, with primary markets contributing 47.1% of SHOP NOI, while secondary and other markets showed higher year-over-year NOI growth SHOP Results of Operations by Market (Q2 2024 vs. Q2 2023) | Markets | Number of Properties | Q2 2024 NOI (thousands USD) | NOI % | Q2 2023 NOI (thousands USD) | Change | Q2 2024 Occupancy | Q2 2023 Occupancy | Basis Point Change | Average Monthly Rate (Q2 2024) |\n| :-------- | :------------------- | :------------------------ | :------ | :------------------------ | :------- | :---------------- | :---------------- | :----------------- | :----------------------------- |\n| Primary | 84 | $13,651 | 47.1% | $12,275 | 11.2 % | 78.1% | 76.4% | 170 | $5,291 |\n| Secondary | 63 | $6,774 | 23.4% | $4,326 | 56.6 % | 78.1% | 77.5% | 60 | $4,889 |\n| Other | 85 | $8,559 | 29.5% | $6,286 | 36.2 % | 81.5% | 80.6% | 90 | $5,178 |\n| **Total / Average SHOP** | **232** | **$28,984** | **100.0%** | **$22,887** | **26.6 %** | **79.0%** | **77.8%** | **120** | **$5,161** | - Top CBSAs by Q2 2024 Total Senior Living NOI include **Washington, DC ($2,159 thousand)**, **Tampa, FL ($1,738 thousand)**, and **Miami, FL ($1,737 thousand)**[35](index=35&type=chunk) [Medical Office and Life Science Portfolio and Same Property - Results of Operations](index=23&type=section&id=Medical%20Office%20and%20Life%20Science%20Portfolio%20and%20Same%20Property%20-%20Results%20of%20Operations) The Medical Office and Life Science Portfolio reported consolidated NOI of $30.3 million in Q2 2024, a 2.9% increase year-over-year, with occupancy at 81.5%, while same property NOI was $31.1 million, but experienced a 5.5% year-over-year decrease, primarily due to a decline in Life Science same property NOI, with Medical Office properties generally showing more stable performance Consolidated Medical Office and Life Science Portfolio Results (Q2 2024 vs. Q2 2023) | Metric (dollars in thousands) | Q2 2024 | Q2 2023 | YoY Change |\n| :---------------------------- | :-------- | :-------- | :--------- |\n| Number of Properties | 101 | 105 | |\n| Square Feet | 8,396 | 8,797 | |\n| Occupancy | 81.5 % | 85.8 % | |\n| Rental Income | $54,555 | $53,368 | |\n| NOI | $30,273 | $29,430 | 2.9% |\n| Cash Basis NOI | $29,862 | $31,817 | (6.1)% |\n| NOI Margin % | 55.5 % | 55.1 % | |\n| Cash Basis NOI Margin % | 55.0 % | 58.5 % | | Same Property Medical Office and Life Science Portfolio Results (Q2 2024 vs. Q2 2023) | Metric (dollars in thousands) | Q2 2024 | Q2 2023 | YoY Change |\n| :---------------------------- | :-------- | :-------- | :--------- |\n| Number of Properties | 92 | 92 | |\n| Square Feet | 7,590 | 7,580 | |\n| Occupancy | 87.4 % | 94.0 % | |\n| Rental Income | $52,971 | $53,895 | |\n| NOI | $31,078 | $32,895 | (5.5)% |\n| Cash Basis NOI | $30,784 | $31,954 | (3.7)% |\n| NOI Margin % | 58.7 % | 61.0 % | |\n| Cash Basis NOI Margin % | 58.3 % | 60.1 % | | - Life Science consolidated NOI increased **16.5% YoY**, while Medical Office consolidated NOI decreased **2.6% YoY**, for same properties, Life Science NOI decreased **11.7% YoY**, and Medical Office NOI decreased **2.1% YoY**[38](index=38&type=chunk)[39](index=39&type=chunk) [SHOP Segment and Same Property - Results of Operations](index=25&type=section&id=SHOP%20Segment%20and%20Same%20Property%20-%20Results%20of%20Operations) The SHOP segment demonstrated strong performance in Q2 2024, with consolidated NOI increasing 26.6% year-over-year to $29.0 million and a sequential increase of 17.3%, occupancy rose to 79.0%, and the average monthly rate increased by 6.1% year-over-year, with same property results mirroring this trend, with NOI up 26.8% year-over-year Consolidated SHOP Segment Results (Q2 2024 vs. Q2 2023) | Metric (dollars in thousands) | Q2 2024 | Q2 2023 | YoY Change |\n| :---------------------------- | :-------- | :-------- | :--------- |\n| Number of Properties | 232 | 234 | |\n| Number of Units | 25,230 | 25,322 | |\n| Occupancy | 79.0 % | 77.8 % | |\n| Average Monthly Rate | $5,161 | $4,862 | 6.1 % |\n| Residents Fees and Services | $308,522 | $284,846 | |\n| Property Operating Expenses | $(279,538) | $(261,959) | |\n| NOI | $28,984 | $22,887 | 26.6% |\n| NOI Margin % | 9.4 % | 8.0 % | | Same Property SHOP Segment Results (Q2 2024 vs. Q2 2023) | Metric (dollars in thousands) | Q2 2024 | Q2 2023 | YoY Change |\n| :---------------------------- | :-------- | :-------- | :--------- |\n| Number of Properties | 217 | 217 | |\n| Number of Units | 24,446 | 24,446 | |\n| Occupancy | 79.6% | 78.0 % | |\n| Average Monthly Rate | $5,171 | $4,877 | 16.0 % |\n| Residents Fees and Services | $301,948 | $278,290 | |\n| Property Operating Expenses | $(271,570) | $(254,327) | |\n| NOI | $30,378 | $23,963 | 26.8% |\n| NOI Margin % | 10.1 % | 8.6 % | | [SHOP Segment - Five Star and Other Operator Managed Communities Results of Operations](index=26&type=section&id=SHOP%20Segment%20-%20Five%20Star%20and%20Other%20Operator%20Managed%20Communities%20Results%20of%20Operations) In Q2 2024, Five Star managed communities generated $23.66 million in NOI, representing an 11.9% NOI margin, while other operator managed communities generated $5.33 million in NOI with a 4.9% margin, Five Star communities showed a modest 2.2% YoY NOI change, whereas other operator communities experienced a significant 2,132.4% YoY NOI increase from a negative base SHOP Segment Results by Manager Type (Q2 2024 vs. Q2 2023) | Metric (dollars in thousands) | Five Star Managed (Q2 2024) | Other Operator Managed (Q2 2024) | Total SHOP Segment (Q2 2024) | Five Star Managed (Q2 2023) | Other Operator Managed (Q2 2023) | Total SHOP Segment (Q2 2023) |\n| :---------------------------- | :-------------------------- | :------------------------------- | :--------------------------- | :-------------------------- | :------------------------------- | :--------------------------- |\n| Number of Properties | 119 | 113 | 232 | 119 | 115 | 234 |\n| Number of Units | 17,654 | 7,576 | 25,230 | 17,699 | 7,623 | 25,322 |\n| Occupancy | 78.9 % | 79.2 % | 79.0 % | 77.9 % | 77.5 % | 77.8 % |\n| Average Monthly Rate | $4,775 | $6,057 | $5,161 | $4,537 | $5,622 | $4,862 |\n| Residents Fees and Services | $199,546 | $108,976 | $308,522 | $186,017 | $98,829 | $284,846 |\n| Property Operating Expenses | $(175,887) | $(103,651) | $(279,538) | $(162,868) | $(99,091) | $(261,959) |\n| NOI | $23,659 | $5,325 | $28,984 | $23,149 | $(262) | $22,887 |\n| NOI Margin % | 11.9 % | 4.9 % | 9.4 % | 12.4 % | (0.3)% | 8.0 % |\n| NOI % Change (YoY) | 2.2 % | 2,132.4 % | 26.6 % | | | | [Portfolio Leasing Summary](index=27&type=section&id=Portfolio%20Leasing%20Summary) For the Medical Office and Life Science Portfolio in Q2 2024, DHC executed 101 thousand square feet of leases (37 thousand new, 64 thousand renewals), with the weighted average GAAP rent change at 12.1%, new leases achieving 17.5% and renewals 9.2%, the total weighted average lease term was 5.6 years, and total leasing costs and concession commitments amounted to $4.1 million Medical Office and Life Science Portfolio Leasing Activity (Q2 2024) | Metric (sq. ft. in thousands) | Q2 2024 | Q1 2024 | Q2 2023 |\n| :---------------------------- | :------ | :------ | :------ |\n| New leases | 37 | 25 | 163 |\n| Renewals | 64 | 76 | 161 |\n| **Total** | **101** | **101** | **324** | % Change in GAAP Rent (Q2 2024) | Lease Type | Q2 2024 | Q1 2024 | Q2 2023 |\n| :--------- | :------ | :------ | :------ |\n| New leases | 17.5 % | 35.3 % | 0.5 % |\n| Renewals | 9.2 % | 7.0 % | 2.1 % |\n| **Total** | **12.1 %** | **11.5 %** | **1.3 %** | Leasing Costs and Concession Commitments (Q2 2024) | Metric (dollars in thousands) | Q2 2024 | Q1 2024 | Q2 2023 |\n| :---------------------------- | :-------- | :-------- | :--------- |\n| New leases | $3,302 | $1,418 | $8,602 |\n| Renewals | $822 | $741 | $2,038 |\n| **Total** | **$4,124** | **$2,114** | **$10,640** | [Tenants Representing 1% or More of Total Annualized Rental Income](index=28&type=section&id=Tenants%20Representing%201%25%20or%20More%20of%20Total%20Annualized%20Rental%20Income) As of June 30, 2024, DHC's top tenant, Advocate Aurora Health, accounts for 6.6% of total annualized rental income, with the top 24 tenants collectively representing 50.4% of total annualized rental income, with a mix of Medical Office, Wellness Center, Life Science, and Senior Living properties Top Tenants by Annualized Rental Income (as of June 30, 2024) | | Tenant Name | Type of Property | Annualized Rental Income (thousands USD) | % of Annualized Rental Income | Expiration |\n| :- | :-------------------------- | :--------------- | :------------------------------------- | :---------------------------- | :---------- |\n| 1 | Advocate Aurora Health | Medical office | $16,939 | 6.6% | 2026 - 2031 |\n| 2 | Life Time Athletic | Wellness center | $12,284 | 4.8% | 2040 - 2044 |\n| 3 | Brookdale Senior Living, Inc. | Senior living | $9,836 | 3.9% | 2032 |\n| 4 | Alamar Biosciences, Inc. | Life science | $6,851 | 2.7% | 2034 |\n| 5 | KSQ Therapeutics, Inc. | Life science | $5,434 | 2.1% | 2032 |\n| 6 | Medtronic, Inc. | Medical office | $5,398 | 2.1% | 2027 - 2028 |\n| 7 | Merck & Co. Inc. | Life science | $5,335 | 2.1% | 2033 |\n| 8 | Stratford Retirement, LLC | Senior living | $5,143 | 2.0% | 2033 |\n| 9 | Sonova Holding AG | Life science | $5,085 | 2.0% | 2033 |\n| 10 | Boston Children's Hospital | Medical office | $4,779 | 1.9% | 2028 |\n| 11 | Magellan Health Inc. | Medical office | $4,688 | 1.8% | 2025 |\n| 12 | Stellar Senior Living, LLC | Senior living | $4,628 | 1.8% | 2027 |\n| 13 | Tokio Marine Holdings Inc. | Medical office | $4,335 | 1.7% | 2024 - 2033 |\n| 14 | Abbvie Inc. | Life science | $3,965 | 1.6% | 2027 |\n| 15 | United Healthcare Services, Inc. | Medical office | $3,926 | 1.5% | 2026 |\n| 16 | Hawaii Pacific Health | Medical office | $3,792 | 1.5% | 2024 - 2029 |\n| 17 | HCA Holdings Inc. | Medical office | $3,704 | 1.5% | 2024 - 2029 |\n| 18 | Revvity, Inc. | Life science | $3,681 | 1.4% | 2028 |\n| 19 | McKesson Corporation | Medical office | $3,668 | 1.4% | 2025 - 2029 |\n| 20 | Duke University | Medical office | $3,366 | 1.3% | 2024 |\n| 21 | New York University | Medical office | $3,245 | 1.3% | 2024 - 2028 |\n| 22 | Ultragenyx Pharmaceutical Inc. | Life science | $3,107 | 1.2% | 2026 |\n| 23 | Sentara Health | Medical office | $3,015 | 1.2% | 2027 - 2032 |\n| 24 | WRA Management, Inc. | Medical office | $2,594 | 1.0% | 2025 - 2045 |\n| All Other Tenants | | | $126,097 | 49.6% | 2024 - 2051 |\n| **Total Tenants** | | | **$254,895** | **100.0%** | | [Medical Office and Life Science Portfolio Lease Expiration Schedule](index=29&type=section&id=Medical%20Office%20and%20Life%20Science%20Portfolio%20Lease%20Expiration%20Schedule) The Medical Office and Life Science Portfolio has an average remaining lease term of 5.4 years, with significant portions of leases, both by square feet and annualized rental income, set to expire between 2027 and 2031, with 17.1% of leased square feet expiring in 2028 and 16.4% of annualized rental income expiring in 2028 - Average remaining lease term (weighted by annualized rental income) for Medical Office and Life Science Portfolio is **5.4 years**[45](index=45&type=chunk) Medical Office and Life Science Portfolio Lease Expiration Schedule (as of June 30, 2024) | Year | Square Feet with Leases Expiring | % of Total Leased Square Feet Expiring | Cumulative % of Total Leased Square Feet Expiring |\n| :------------------ | :------------------------------- | :------------------------------------- | :------------------------------------------------ |\n| 2024 | 222,370 | 3.2% | 3.2% |\n| 2025 | 621,026 | 9.1% | 12.3% |\n| 2026 | 743,245 | 10.9% | 23.2% |\n| 2027 | 971,503 | 14.2% | 37.4% |\n| 2028 | 1,168,501 | 17.1% | 54.5% |\n| 2029 | 630,072 | 9.2% | 63.7% |\n| 2030 | 318,779 | 4.7% | 68.4% |\n| 2031 | 830,835 | 12.1% | 80.5% |\n| 2032 | 355,648 | 5.2% | 85.7% |\n| 2033 and thereafter | 984,378 | 14.3% | 100.0% |\n| **Total** | **6,846,357** | **100.0%** | | Annualized Rental Income Expiring (as of June 30, 2024) | Year | Annualized Rental Income Expiring (thousands USD) | % of Total Annualized Rental Income Expiring | Cumulative % of Total Annualized Rental Income Expiring |\n| :------------------ | :---------------------------------------------- | :------------------------------------------- | :------------------------------------------------------ |\n| 2024 | $6,950 | 3.2% | 3.2% |\n| 2025 | $17,565 | 8.1% | 11.3% |\n| 2026 | $23,507 | 10.9% | 22.2% |\n| 2027 | $24,293 | 11.3% | 33.5% |\n| 2028 | $35,354 | 16.4% | 49.9% |\n| 2029 | $18,721 | 8.7% | 58.6% |\n| 2030 | $8,435 | 3.9% | 62.5% |\n| 2031 | $25,199 | 11.7% | 74.2% |\n| 2032 | $13,527 | 6.3% | 80.5% |\n| 2033 and thereafter | $42,077 | 19.5% | 100.0% |\n| **Total** | **$215,628** | **100.0%** | | [Non-Segment Lease Expiration Schedule](index=30&type=section&id=Non-Segment%20Lease%20Expiration%20Schedule) DHC's non-segment properties, primarily triple net leased senior living communities and wellness centers, have an average remaining lease term of 10.5 years, with the largest portion of annualized rental income (48.9%) set to expire in 2033 and thereafter, indicating a long-term lease structure for this segment - Average remaining lease term (weighted by annualized rental income) for Non-Segment properties is **10.5 years**[46](index=46&type=chunk) Non-Segment Lease Expiration Schedule (as of June 30, 2024) | Year | Number of Properties | Number of Units or Square Feet | Annualized Rental Income Expiring (thousands USD) | % of Total Annualized Rental Income Expiring | Cumulative % of Total Annualized Rental Income Expiring |\n| :------------------ | :------------------- | :----------------------------- | :---------------------------------------------- | :------------------------------------------- | :------------------------------------------------------ |\n| 2024 | 0 | 0 | $0 | 0% | 0% |\n| 2025 | 1 | 0 | $0 | 0% | 0% |\n| 2026 | 0 | 0 | $0 | 0% | 0% |\n| 2027 | 4 | 533 units | $4,628 | 11.8% | 11.8% |\n| 2028 | 0 | 0 | $0 | 0% | 11.8% |\n| 2029 | 1 | 155 units | $547 | 1.4% | 13.2% |\n| 2030 | 5 | 283 units and 129,500 sq. ft. | $5,046 | 12.9% | 26.1% |\n| 2031 | 0 | 0 | $0 | 0% | 26.1% |\n| 2032 | 18 | 876 units | $9,836 | 25.0% | 51.1% |\n| 2033 and thereafter | 9 | 15 units and 682,500 sq. ft. | $19,210 | 48.9% | 100.0% |\n| **Total** | **37** | | **$39,267** | **100.0%** | | Appendix [Company Profile and Research Coverage](index=31&type=section&id=Company%20Profile%20and%20Research%20Coverage) Diversified Healthcare Trust (DHC) is a REIT focused on high-quality healthcare properties across the U.S., with a $7.2 billion portfolio of 370 properties, managed by The RMR Group, an alternative asset management company, and covered by equity research analysts from B. Riley Securities and RBC Capital Markets, as well as Moody's Investors Service - DHC is a REIT focused on owning high-quality healthcare properties throughout the United States, with a portfolio of **370 properties** in 36 states and Washington, D.C., totaling approximately **8.4 million square feet** of life science and medical office properties and over **27,000 senior living units**[48](index=48&type=chunk) - DHC is managed by The RMR Group (Nasdaq: RMR), an alternative asset management company with over **$41 billion of real estate assets under management** as of June 30, 2024[48](index=48&type=chunk) - DHC is followed by equity research analysts from B. Riley Securities, Inc. and RBC Capital Markets, and has ratings from Moody's Investors Service[48](index=48&type=chunk) [Governance Information](index=32&type=section&id=Governance%20Information) DHC's governance structure includes a Board of Trustees with both managing and independent trustees, and a team of executive officers responsible for the company's operations, with key personnel including Christopher J. Bilotto as President and CEO, and Adam D. Portnoy as Chair of the Board & Managing Trustee - Board of Trustees includes Christopher J. Bilotto (Managing Trustee), Lisa Harris Jones (Lead Independent Trustee), Dawn K. Neher (Independent Trustee), Jeffrey P. Somers (Independent Trustee), John L. Harrington (Independent Trustee), Phyllis M. Hollis (Independent Trustee), and Adam D. Portnoy (Chair of the Board & Managing Trustee)[49](index=49&type=chunk) - Executive Officers include Christopher J. Bilotto (President and Chief Executive Officer) and Matthew C. Brown (Chief Financial Officer and Treasurer)[49](index=49&type=chunk) [Calculation and Reconciliation of NOI and Cash Basis NOI](index=33&type=section&id=Calculation%20and%20Reconciliation%20of%20NOI%20and%20Cash%20Basis%20NOI) This section provides a detailed reconciliation of DHC's net loss to Net Operating Income (NOI) and Cash Basis NOI for multiple quarters, for Q2 2024, NOI was $67.3 million and Cash Basis NOI was $66.5 million, reflecting adjustments for non-cash items like straight-line rent and amortization Reconciliation of Net Loss to NOI and Cash Basis NOI (Q2 2024) | Metric (dollars in thousands) | Q2 2024 | Q1 2024 | Q2 2023 |\n| :---------------------------------------------------------------- | :--------- | :--------- | :--------- |\n| Net loss | $(97,861) | $(86,259) | $(72,571) |\n| Equity in net losses (earnings) of investees | $12,307 | $(1,898) | $(2,929) |\n| Income tax expense | $170 | $187 | $221 |\n| Loss on modification or early extinguishment of debt | $209 | $0 | $0 |\n| Interest expense | $58,702 | $57,576 | $47,384 |\n| Interest and other income | $(2,403) | $(2,237) | $(5,134) |\n| Losses (gains) on sale of properties | $13,213 | $5,874 | $0 |\n| Impairment of assets | $6,545 | $12,142 | $11,299 |\n| Acquisition and certain other transaction related costs | $1,826 | $86 | $6,043 |\n| General and administrative | $6,262 | $7,568 | $7,284 |\n| Depreciation and amortization | $68,357 | $70,133 | $68,394 |\n| **NOI** | **$67,327** | **$63,172** | **$59,991** |\n| Non-cash straight line rent adjustments included in rental income | $(656) | $(291) | $4,457 |\n| Lease value amortization included in rental income | $29 | $28 | $25 |\n| Lease termination fees included in rental income | $0 | $(203) | $(2,183) |\n| Non-cash amortization included in property operating expenses | $(199) | $(199) | $(199) |\n| **Cash Basis NOI** | **$66,501** | **$62,507** | **$62,091** | [Calculation and Reconciliation of NOI, Cash Basis NOI, Same Property NOI and Same Property Cash Basis NOI by Segment](index=34&type=section&id=Calculation%20and%20Reconciliation%20of%20NOI,%20Cash%20Basis%20NOI,%20Same%20Property%20NOI%20and%20Same%20Property%20Cash%20Basis%20NOI%20by%20Segment) This section provides a segment-level reconciliation of NOI, Cash Basis NOI, Same Property NOI, and Same Property Cash Basis NOI, for Q2 2024, the Medical Office and Life Science Portfolio reported Same Property Cash Basis NOI of $30.8 million, while the SHOP segment reported $30.4 million, highlighting the performance of consistent properties within each segment Segment-level Reconciliation of NOI and Cash Basis NOI (Q2 2024) | Metric (dollars in thousands) | Medical Office and Life Science Portfolio | SHOP | Non-Segment | Total |\n| :---------------------------------------------------------------- | :---------------------------------------- | :-------- | :---------- | :-------- |\n| Rental income / reside

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Diversified Healthcare (DHC) is one of the several great candidates that made it through the screen. While there are numerous reasons why this stock is a great choice, here are the most vital ones: Moreover, the momentum for DHC is fa ...

Diversified Healthcare Trust (NASDAQ:DHC) Q1 2024 Earnings Call Transcript May 7, 2024 10:00 AM ET Company Participants Kevin Brady - Director of Investor Relations Chris Bilotto - President and Chief Executive Officer Matthew Brown - Chief Financial Officer Conference Call Participants Bryan Maher - B. Riley Securities Aaron Hecht - Citizens JMP Operator Good morning, and welcome to the Diversified Healthcare Trust First Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [ ...

Diversified Healthcare (DHC) came out with quarterly funds from operations (FFO) of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.05 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this residential care real estate investment trust would post FFO of $0.05 per share when it actually produced FFO of $0.03, delivering a surprise of -40%.Over the last four quarters, the company has not been able to surpass cons ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-15319 DIVERSIFIED HEALTHCARE TRUST (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Maryla ...

DIVERSIFIED HEALTHCARE The Horizon Club 1208 South Military Trail Deerfield Beach, FL Table of Contents | FINANCIAL RESULTS | Diversified Healthcare Trust Announces First Quarter 2024 Financial Results | | | --- | --- | --- | | | First Quarter 2024 Highlights | | | | First Quarter 2024 Results | | | FINANCIALS | Key Financial Data | | | | Condensed Consolidated Balance Sheets | | | | Condensed Consolidated Statements of Income (Loss). Joseph and Consolition and and and and and and and and and and and and on ...

Diversified Healthcare (DHC) closed the latest trading day at $2.59, indicating a -1.15% change from the previous session's end. The stock fell short of the S&P 500, which registered a loss of 0.14% for the day. Meanwhile, the Dow lost 0.77%, and the Nasdaq, a tech-heavy index, added 0.17%.Coming into today, shares of the residential care real estate investment trust had lost 10.88% in the past month. In that same time, the Finance sector gained 4.92%, while the S&P 500 gained 5.34%.Analysts and investors a ...

Diversified Healthcare (DHC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this residential care real estate investment trust have returned -4.2% over the past month versus the Zacks S&P 500 composite's +2.1% change. The Zacks REIT and Equity Trust - Other industry, to which Diversified Healthcare belongs, has gained 3.1% over this period. Now the key question is: Wh ...

pxhidalgo/iStock via Getty Images On our previous coverage of Diversified Healthcare Trust (NASDAQ:DHC), we rejected the idea that the stock was worth anywhere close to $9.00. This was contrary to speculation by Flat Footed LLC, which had established a large position based on that belief. This default flies in the face of the $9.00 NAV as suggested by Flat Footed LLC. Some investors may reject this NAV drop, but this is about what we have seen for many REITs. Source: Seeking Alpha. We suggested that bul ...